Discovering Opportunities: 3 Penny Stocks With Market Caps Over $500M

In This Article:

As the U.S. market navigates a landscape of tariff exemptions and fluctuating tech stock performance, investors are keenly observing opportunities that may arise from these developments. For those interested in smaller or newer companies, penny stocks — despite their somewhat outdated moniker — remain a relevant investment area. When supported by solid financial health, these stocks can offer a blend of value and growth potential that might not be as prominent in larger firms.

Top 10 Penny Stocks In The United States

Name

Share Price

Market Cap

Financial Health Rating

Safe Bulkers (NYSE:SB)

$3.48

$364.86M

★★★★☆☆

Tuya (NYSE:TUYA)

$2.02

$1.2B

★★★★★★

CI&T (NYSE:CINT)

$4.87

$651.45M

★★★★★☆

Smith Micro Software (NasdaqCM:SMSI)

$0.796

$14.15M

★★★★☆☆

Global Self Storage (NasdaqCM:SELF)

$4.93

$55.56M

★★★★★☆

Flexible Solutions International (NYSEAM:FSI)

$3.83

$48.44M

★★★★★★

Imperial Petroleum (NasdaqCM:IMPP)

$2.33

$70.67M

★★★★★★

BAB (OTCPK:BABB)

$0.7755

$5.63M

★★★★★☆

QuantaSing Group (NasdaqGM:QSG)

$3.08

$226.43M

★★★★★★

Lifetime Brands (NasdaqGS:LCUT)

$3.99

$88.43M

★★★★★☆

Click here to see the full list of 795 stocks from our US Penny Stocks screener.

We'll examine a selection from our screener results.

Organogenesis Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for advanced wound care and surgical and sports medicine markets in the United States, with a market cap of $540.29 million.

Operations: The company generates revenue primarily from its Regenerative Medicine segment, amounting to $482.04 million.

Market Cap: $540.29M

Organogenesis Holdings Inc., with a market cap of US$540.29 million, recently joined the S&P Biotechnology Select Industry Index, highlighting its presence in the sector. Despite being unprofitable and experiencing high share price volatility, it reported a net income of US$7.67 million for Q4 2024, a turnaround from the previous year's loss. The company is debt-free and has strong short-term assets exceeding liabilities by over US$200 million, providing financial stability. However, significant insider selling raises concerns about internal confidence despite forecasts of substantial earnings growth and trading at good value compared to peers.

NasdaqCM:ORGO Revenue & Expenses Breakdown as at Apr 2025
NasdaqCM:ORGO Revenue & Expenses Breakdown as at Apr 2025

Alight

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Alight, Inc. is a technology-enabled services company operating globally with a market cap of approximately $2.64 billion.